Ocostec seeking to develop new RA drug

Published: 2011-11-09 06:57:00

Updated: 2011-11-09 06:57:00

Oscotec Inc., bone specialized bioengineering company, said that it presented its experimental drug candidate for the treatment of rheumatoid arthritis (RA) in 2011 Annual Scientific meeting of the American College of Rheumatology (ACR), which are being held in Chicago between November 5-9.

SK...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK